The United States Anti-Doping Agency has suspended veteran UFC fighter C.B. Dollaway for two years after he tested positive for multiple banned substances.
“Dollaway, 35, tested positive for anastrozole, growth hormone releasing peptide 2 (GHRP-2 or pralmorelin), a metabolite of GHRP-2, and GHRP-6 as the result of an out-of-competition urine sample he provided on December 19, 2018. Anastrozole is a Specified Substance in the class of Hormone and Metabolic Modulators, while GHRP-2 and GHRP-6 are Specified Substances in the class of Peptide Hormones, Growth Factors, Related Substances and Mimetics. Dollaway also tested positive for clomiphene in an out-of-competition urine sample collected on February 9, 2019. Dollaway received an over-the-limit intravenous (IV) infusion on December 13, 2018,” USADA officials stated.
The fighter himself issued a statement of his own saying that he never knowingly ingested any of the banned substances that showed up in his drug tests.
“In light of the recent decision made by USADA to issue me a two year sanction, I want it to be very clear that I did not knowingly nor intentionally take any performance enhancing drugs. As many people close to me are aware, I suffered a serious back injury in 2016. With my insurance capped out, I needed to find alternative solution if I wanted to continue to compete in mixed martial arts. I traveled to Mexico to have a stem cell procedure done and ended up coming into contact with the mentioned substances. I am sorry to let my friends, family and fans down. I want to personally thank Donna Marcolini, the VP of health and performance of the UFC, for her assistance and for believing in me. I will take this time to continue working on my health and hopefully be ready to come back in 2020 as a healthy athlete/fighter for the first time since 2016”, Dollaway wrote on Instagram.